DE3684225D1 - Verfahren zur herstellung von 3-imidazolylmethyltetrahydrocarbazolonen. - Google Patents

Verfahren zur herstellung von 3-imidazolylmethyltetrahydrocarbazolonen.

Info

Publication number
DE3684225D1
DE3684225D1 DE8686305673T DE3684225T DE3684225D1 DE 3684225 D1 DE3684225 D1 DE 3684225D1 DE 8686305673 T DE8686305673 T DE 8686305673T DE 3684225 T DE3684225 T DE 3684225T DE 3684225 D1 DE3684225 D1 DE 3684225D1
Authority
DE
Germany
Prior art keywords
sub
sup
alkyl
cycloalkyl
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686305673T
Other languages
English (en)
Inventor
Alexander William Oxford
Colin David Eldred
James Angus Bell
Ian Harold Coates
George Blanch Ewan
David Cedric Humber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DE3684225D1 publication Critical patent/DE3684225D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Glass Compositions (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE8686305673T 1985-07-24 1986-07-23 Verfahren zur herstellung von 3-imidazolylmethyltetrahydrocarbazolonen. Expired - Lifetime DE3684225D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858518741A GB8518741D0 (en) 1985-07-24 1985-07-24 Process

Publications (1)

Publication Number Publication Date
DE3684225D1 true DE3684225D1 (de) 1992-04-16

Family

ID=10582813

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686305673T Expired - Lifetime DE3684225D1 (de) 1985-07-24 1986-07-23 Verfahren zur herstellung von 3-imidazolylmethyltetrahydrocarbazolonen.

Country Status (12)

Country Link
US (1) US4739072A (de)
EP (1) EP0219929B1 (de)
JP (1) JPH07612B2 (de)
KR (1) KR920001670B1 (de)
AT (1) ATE73451T1 (de)
CA (1) CA1281722C (de)
DE (1) DE3684225D1 (de)
ES (1) ES2000935A6 (de)
FI (1) FI84350C (de)
GB (1) GB8518741D0 (de)
GR (1) GR861926B (de)
PT (1) PT83043B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8617994D0 (en) * 1986-07-23 1986-08-28 Glaxo Group Ltd Heterocyclic compounds
GR871809B (en) * 1986-11-28 1988-03-07 Glaxo Group Ltd Process for the preparation of tricyclic ketones
US5360800A (en) * 1987-09-03 1994-11-01 Glaxo Group Limited Tetrahydro-1H-pyrido[4,3-b]indol-1-one derivatives
EP0317088A1 (de) * 1987-10-22 1989-05-24 Glaxo Group Limited Ketonderivate
US5225431A (en) * 1987-10-23 1993-07-06 Burroughs Wellcome Co. Therapeutic substituted indole compounds and compositions thereof
JPH02167280A (ja) * 1988-08-15 1990-06-27 Glaxo Group Ltd ラクタム誘導体
WO1990012569A1 (en) 1989-04-21 1990-11-01 Sandoz Ag Therapeutic use of 5-ht3 receptor antagonists
DE4010797A1 (de) * 1990-04-04 1991-10-10 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung
ES2043535B1 (es) * 1992-03-13 1994-08-01 Vita Invest Sa Procedimiento para la obtencion de la 1,2,3,9-tetrahidro-9-metil-3-(2-metil-1h-imidazol-1-il)metil*-4h-carbazol-4-ona.
HU212934B (en) 1992-10-14 1996-12-30 Richter Gedeon Vegyeszet Process for producing novel alkoxalylated carbazolone derivatives
YU32003A (sh) * 2000-10-30 2006-05-25 Teva Pharmaceutical Industries Ltd. Novi kristalni i solvatni oblici ondansteron hlorovodonika i postupci za njihovo pripremanje
US20020115707A1 (en) * 2001-01-11 2002-08-22 Rami Lidor-Hadas Process for preparing pure ondansetron hydrochloride dihydrate
PL373191A1 (en) * 2002-04-29 2005-08-22 Teva Gyogyszergyar Reszvenytarsasag Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one
US20050131045A1 (en) * 2002-04-30 2005-06-16 Judith Aronhime Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them
FI6164U1 (fi) * 2003-01-09 2004-03-15 Synthon Bv Ondansetronmuotoja
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
US20090170872A1 (en) * 2005-07-05 2009-07-02 Orchid Research Laboratories Limited Compounds and Their Pharmaceutical Use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3592824A (en) * 1970-03-12 1971-07-13 Miles Lab 3-substituted amino-1,2,3,4-tetrahydrocarbazoles
US3892766A (en) * 1974-06-03 1975-07-01 Warner Lambert Co Process for the preparation of 4-keto-1,2,3,4-tetrahydrocarbazole
GR73560B (de) * 1979-02-24 1984-03-15 Pfizer
EP0073849A1 (de) * 1981-09-03 1983-03-16 Schering Corporation Phenyl-1,2,3,4-tetrahydrocarbazole, ihre Herstellung und pharmazeutische Zubereitungen, die sie enthalten
FR2561244B1 (fr) * 1984-01-25 1988-03-04 Glaxo Group Ltd Composes heterocycliques du type tetrahydrocarbazolone, procede pour leur preparation et composition pharmaceutique les comprenant

Also Published As

Publication number Publication date
FI863019A (fi) 1987-01-25
GR861926B (en) 1986-09-05
JPH07612B2 (ja) 1995-01-11
ATE73451T1 (de) 1992-03-15
ES2000935A6 (es) 1988-04-01
FI84350B (fi) 1991-08-15
EP0219929A1 (de) 1987-04-29
FI863019A0 (fi) 1986-07-23
US4739072A (en) 1988-04-19
CA1281722C (en) 1991-03-19
PT83043B (pt) 1989-02-28
JPS6277380A (ja) 1987-04-09
KR870001198A (ko) 1987-03-12
EP0219929B1 (de) 1992-03-11
FI84350C (fi) 1991-11-25
KR920001670B1 (ko) 1992-02-22
GB8518741D0 (en) 1985-08-29
PT83043A (en) 1986-08-01

Similar Documents

Publication Publication Date Title
DE3684225D1 (de) Verfahren zur herstellung von 3-imidazolylmethyltetrahydrocarbazolonen.
DE3684235D1 (de) Verfahren zur herstellung von 3-imidazolylmethyltetrahydrocarbazolonen.
ATE126219T1 (de) Benzimidazolderivate, verfahren zu deren herstellung und anwendung.
ATE127801T1 (de) Pyrazolopyridinverbindungen und verfahren zu ihrer herstellung.
ATE246676T1 (de) Tetrahydrochinolinderivate mit selektive aktivität für retinoid x rezeptoren
KR860009007A (ko) 피페리딜리덴 디하이드로-디벤조[a,d]-사이클로헵텐의 제조방법
DE3675226D1 (de) Triazinderivate, verfahren zur herstellung der derivate und die derivate als wirksamen bestandteil enthaltende herbizide.
AT380471B (de) Verfahren zur herstellung von neuen 2-oxoazetidin-derivate
ATE285410T1 (de) Naphthyridinderivate oder salze davon
ATE19773T1 (de) Nitroaliphatische verbindungen, verfahren zu deren herstellung und deren verwendung.
DE69635057D1 (de) Verfahren zur herstellung von campothecinderivate
EP0356098A3 (de) Lactamderivate
DE69324854D1 (de) Pyridazinone-Derivate und Verfahren zur deren Herstellung
ES2008067T3 (es) Analogos de prostaciclina (pgi2).
ATE17484T1 (de) Benzodioxan-imidazolin-verbindungen, verfahren zu deren herstellung und deren anwendung.
ATE202350T1 (de) Verfahren zur herstellung von sulfonylharnstoffderivaten
KR850001165A (ko) 중추 신경계 활성을 갖는 피롤리디논의 제조방법
ATE107657T1 (de) Verfahren zur herstellung von zwischenprodukten für 11-beta,16-alpha,17-alpha,21- tetrahydroxypregna-3-20-dione 16-alpha,17-alpha- acetal und deren 21-ester.
KR910004632A (ko) 신규한 1-옥사-2-옥소-8-아자스피로[4,5]데칸 유도체와 그들을 포함하는 약제학적 조성물 및 그 제조방법
DE69007203D1 (de) Imidazolderivate, Verfahren zu deren Herstellung und diese enthaltende Antiulkusmittel.
KR920002619A (ko) 오르가노실란 유도체, 이를 함유하는 약제학적 조성물 및 이의 제조방법
ATE232884T1 (de) Verfahren zur herstellung von kondensationsverbindungen
DE3680807D1 (de) Dioxolobenzisoxazolderivate und verfahren zu ihrer herstellung.
KR830005213A (ko) 이소퀴놀린유도체의 제조방법

Legal Events

Date Code Title Description
8364 No opposition during term of opposition